The group's principal activities are to conduct research, development and manufacture immunological products for the treatment of life-threatening diseases. The group produces a natural alpha interferon product named multiferon(R) from human white blood cells, also known as leukocytes. Natural interferon stimulates and modulates the human immune system. The group also manufactures medical therapies that stops the growth of various viruses including those associated with diseases such as hepatitis, multiple sclerosis, HIV/aids and some forms of cancer. The group operates in Sweden, Scotland and Germany.